5,6-MDO-MiPT

5,6-MDO-MiPT
Clinical data
Other names5,6-Methylenedioxy-N-methyl-N-isopropyltryptamine
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Onset of actionUnknown[1]
Duration of actionUnknown[1]
Identifiers
  • N-[2-(5H-[1,3]dioxolo[4,5-f]indol-7-yl)ethyl]-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H20N2O2
Molar mass260.337 g·mol−1
3D model (JSmol)
  • CC(C)N(C)CCC1=CNC2=CC3=C(C=C21)OCO3
  • InChI=1S/C15H20N2O2/c1-10(2)17(3)5-4-11-8-16-13-7-15-14(6-12(11)13)18-9-19-15/h6-8,10,16H,4-5,9H2,1-3H3
  • Key:OZKGXOZBACDFIQ-UHFFFAOYSA-N

5,6-MDO-MiPT, or 5,6-methylenedioxy-N-methyl-N-isopropyltryptamine, is a lesser-known chemical compound of the tryptamine family.[1] It is the 5,6-methylenedioxy derivative of methylisopropyltryptamine (MiPT) and an analogue of 5-MeO-MiPT.[1] In his 1991 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose range as greater than 50 mg orally and its duration as unknown.[1] The drug produced few to no effects, with effects including parasthesia and lightheadedness, at doses of up to 75 mg orally.[1] Its chemical synthesis has been described.[1] 5,6-MDO-MiPT was first described in the scientific literature by 1982.[2]

See also

References

  1. ^ a b c d e f g h Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
  2. ^ Grotjahn DB (1983). "Synthesis and characterization of 5-H-1,3-dioxolo[4,5-f]indoleethylamines". Journal of Heterocyclic Chemistry. 20 (4): 1031–1036. doi:10.1002/jhet.5570200438. ISSN 0022-152X. Retrieved 4 November 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.